resources

Jubilant Pharmova Ltd.

NSE: JUBLPHARMA

BSE: 530019

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

936.90+4.7 (+0.50%)

23 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Jubilant Pharmova Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	28May 2Jun 2Aug 8Aug 31Oct	3Feb 9Feb	—	—	—
Presentations	—	—	—	—	—	—	—	—	18Jun	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Jubilant Pharmova Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Newspaper Publication23 Oct 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Newspaper Publication22 Oct 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Postal Ballot21 Oct 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice
Credit Rating21 Oct 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Credit Rating
Credit Rating14 Oct 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 - Credit Rating
Raising of Funds12 Oct 2026
Announcement under Regulation 30 (LODR)-Raising of Funds
Issue of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures on Private Placement Basis
Outcome of Board Meeting12 Oct 2026
Board Meeting Outcome for Issuance Of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (Ncds) On Private Placement Basis
Issuance of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (NCDs) on Private Placement Basis
General8 Oct 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under regulation 30
Board Meeting7 Oct 2026
Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws, And To Approve Seeking Shareholders'' Approval, As May Be Required
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve To consider and approve raising ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20185 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended September 30, 2026
Closure of Trading Window29 Sept 2026
Closure of Trading Window
Intimation regarding Closure of Trading Window for the Quarter ended September 30, 2026
General28 Sept 2026
Specimen Letter Sent To Shareholders For Withheld Of Dividend For FY 2025-26
Specimen letter sent to shareholders for withheld of dividend for FY 2025-26
General11 Sept 2026
Update On USFDA Spokane
Update on USFDA Spokane
General1 Sept 2026
Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST
Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST
Newspaper Publication29 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Relodgement and KYC Updation
General28 Aug 2026
Receipt Of Show Cause Notice - Jubilant Generics Limited
Receipt of Show Cause Notice - Jubilant Generics Limited
AGM26 Aug 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report
AGM26 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM
General23 Aug 2026
USFDA Approval For Line 3, Contract Manufacturing Facility, Spokane, U.S.A
USFDA Approval for Line 3, Contract manufacturing facility, Spokane, USA
Postal Ballot17 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Outcome of Postal Ballot

Frequently Asked Questions

Where can I download the annual report of Jubilant Pharmova Ltd.?

Annual reports of Jubilant Pharmova Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Jubilant Pharmova Ltd.?

Quarterly earnings results and presentations of Jubilant Pharmova Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Jubilant Pharmova Ltd. publish earnings call transcripts?

Earnings call transcripts of Jubilant Pharmova Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Jubilant Pharmova Ltd.?

Investor presentations and annual day presentations of Jubilant Pharmova Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Jubilant Pharmova Ltd.?

Corporate announcements and regulatory filings of Jubilant Pharmova Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Jubilant Pharmova Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Jubilant Pharmova Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Jubilant Pharmova Ltd.?

The ISIN (International Securities Identification Number) of Jubilant Pharmova Ltd. is INE700A01033. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Jubilant Pharmova Ltd. listed?

Jubilant Pharmova Ltd. is listed on NSE and BSE. The NSE symbol is JUBLPHARMA and the BSE code is -.

Where can I find the shareholding pattern of Jubilant Pharmova Ltd.?

The quarterly shareholding pattern of Jubilant Pharmova Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Jubilant Pharmova Ltd. on Sharpely?

Share price data for Jubilant Pharmova Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.